Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
TLPH
SellHot AirTalphera, Inc. · Healthcare · United States · $62M · Avg Vol: $292K/d
24
StockRankGet insider-trade alerts
Q
23
V
25
M
63
P/E (TTM)
—
ROE
-143.4%
D/E
0.5x
Dividend %
—
COMPANY DESCRIPTION
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 0 | 0.7M | 0 | 28.0K | -79.3% | — | — | 0.2M | 167.3% |
| EPS | — | 0.91 | -0.42 | -0.16 | -0.34 | — | -0.23 | -0.20 | -0.25 | — |
| Shares | — | 51.9M | 51.9M | 51.9M | 49.3M | -5.0% | 51.9M | — | — | — |
| Debt | 18.6M | 5.4M | — | — | — | -71.2% | 6.5M | — | — | — |
| Equity | — | 21.8M | 14.1M | 8.0M | 17.0M | -7.9% | — | — | — | — |
| Op CF | — | -28.3M | -17.5M | -12.7M | -11.4M | — | -12.3M | — | — | — |
| Inv CF | — | 36.5M | -0.5M | 3.8M | -14.3M | — | — | — | — | — |
| Fin CF | — | -0.5M | 3.5M | 12.0M | 22.7M | — | — | — | — | — |
Loading 1Y...
PRICE (1Y)-8.4%
SMA 50SMA 200
Close
$1.20
RSI (14)
52.6
52W High
$1.57
From 52W High
0.8%
SCORE BREAKDOWN
Quality
23
ROIC
-60.4%12.6
ROE
-143.4%6.0
GP/Assets
-22.6%4.4
Op. Margin
-1474700.0%0.1
FCF/Assets
-23.1%18.2
Piotroski
576.6
Int. Cover
—N/A
D/E Ratio
0.45x31.1
Current Ratio
4.29x67.8
Value
25
P/E (TTM)
—N/A
EV/EBITDA
—N/A
P/FCF
—N/A
P/B
3.3x42.9
P/S
62287.0x0.1
Div Yield
—N/A
Momentum
63
52W High %
76%60.9
RS 6M
21%81.7
SMA 50/200
1.25x90.8
EPS Rev 4W
+9.3%88.5
EPS Rev 12W
—N/A
EPS Improve
-7%19.5
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$62M
P/E (Forward)
-4.9x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TLPH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| TLPH | Talphera, Inc.(you) | $62M | 24 | Sell |
| SCYX | SCYNEXIS, Inc. | $54M | 31 | Sell |
| CWEB.TO | Charlotte's Web Holdings, Inc. | $80M | 15 | Strong Sell |
| CTOR | Citius Oncology, Inc. | $82M | 6 | Strong Sell |
| DERM | Journey Medical Corporation | $211M | 24 | Sell |
| LFCR | Lifecore Biomedical, Inc. | $172M | 16 | Strong Sell |
| CPIX | Cumberland Pharmaceuticals Inc. | $127M | 38 | Hold |
| ORGO | Organogenesis Holdings Inc. | $224M | 29 | Sell |
| JUSH.CN | Jushi Holdings Inc. | $110M | 43 | Hold |
| SIGA | SIGA Technologies, Inc. | $220M | 30 | Sell |
Peer medians: ROE -30.5% · P/E 27.0x · Gross margin 58.3%